Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Pyxus International Q4 Earnings Call Highlights

Pyxus International (OTCMKTS:PYYX) reported a sharply higher fourth quarter and record full-year adjusted EBITDA for fiscal 2026, with management pointing to strong shipment volumes, disciplined cost control and improved leverage as key outcomes from a year marked by shifting tobacco leaf supply con

Ciena Q2 Earnings Call Highlights

Ciena (NYSE:CIEN) reported another record quarter for fiscal 2026, with management pointing to AI-related network demand from cloud providers and renewed spending by service providers as major drivers of growth. On the company’s fiscal second-quarter earnings call, President and CEO Gary Smith said

Ulta's Q1 Report Primes It for a Beauty of a Rebound

Ulta's Q1 Report Primes It for a Beauty of a Rebound

Ulta is setting up for a robust rebound as growth initiatives gain traction and margins outperform. Analysts forecast a 40% upside and institutions are buying.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Commerzbank CEO Touts AI-Driven 2030 Plan, Calls UniCredit Offer Unattractive

Commerzbank (ETR:CBK) Chief Executive Bettina Orlopp said the German lender’s updated “Momentum 2030” strategy is built on continued revenue growth, lower costs and efficiency gains from artificial intelligence, while reiterating that the bank sees UniCredit’s current takeover offer as unattractive.

Transcontinental Q2 Earnings Call Highlights

Transcontinental (TSE:TCL.A) reported lower second-quarter revenue and slightly lower adjusted profitability from continuing operations, while management said it expects stronger results in the second half of fiscal 2026 following recent contract wins, cost reductions and the national rollout of its

Canaccord Genuity Group Q4 Earnings Call Highlights

Canaccord Genuity Group (TSE:CF) reported a record fiscal 2026 revenue total and sharply higher adjusted profitability, as stronger capital markets activity and continued growth in wealth management helped offset uneven market conditions during the fourth quarter. Chairman and CEO Dan Daviau said t

From Runway to Riches: Victoria's Secret's New Look

Victoria's Secret engineered a turnaround and triggered a historic short squeeze by restoring pricing power and reviving its core brand identity.

inkl

Read news from The Economist, FT, and more,
with one subscription

Fifth Third’s Big Bet Is On

Fifth Third’s Big Bet Is On

Fifth Third Bancorp is transforming through its Comerica merger, expanding scale, boosting earnings potential, and strengthening long-term growth prospects

Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach

Ardelyx (NASDAQ:ARDX) executives said at the Jefferies Global Healthcare Conference that the company is focused on expanding demand for its commercial products, IBSRELA and XPHOZAH, while continuing to invest in its pipeline and positioning the business for sustainable profitability. Chief Financia

Dell's AI Toll Bridge Is Paved with Record Margins

Dell's AI Toll Bridge Is Paved with Record Margins

Dell Technologies is transforming global artificial intelligence infrastructure by expanding operating margins and securing massive institutional investments.

As AI Data Breaches Become More Common, This Cybersecurity ETF Is Surging

As AI Data Breaches Become More Common, This Cybersecurity ETF Is Surging

AI-driven cyberattacks are surging, boosting global security spending toward $663 billion annually through 2033 and fueling a 49% rally for the Amplify Cybersecurity ETF.

Mitie Group H2 Earnings Call Highlights

Mitie Group (LON:MTO) reported double-digit growth in revenue and operating profit for the year ended March 31, 2026, as management said the facilities management company remains on track to deliver its three-year strategic plan through FY 2027. Chief Executive Officer Phil Bentley said the company

CMC Markets H2 Earnings Call Highlights

CMC Markets (LON:CMCX) said it delivered a stronger financial performance in fiscal 2026 as institutional and business-to-business activity continued to scale, while management outlined plans for further investment in retail growth, product expansion and major banking partnerships. Founder and CEO

Apogee Therapeutics Readies Zumi for Phase 3 With Blackstone Backing

Apogee Therapeutics (NASDAQ:APGE) executives said the company is preparing to move its lead drug candidate, zumilokibart, into Phase 3 testing later this year after reporting Phase 2b data in atopic dermatitis and securing a major financing agreement with Blackstone. Speaking at a Jefferies-hosted

Get all your
news in one place.

100's of premium titles.
One news app.

American Public Education Unveils 2029 Growth Plan Fueled by Military and Nursing Programs

American Public Education (NASDAQ:APEI) outlined a four-year growth plan at a William Blair conference, with Chief Executive Officer Angie Selden saying the company expects revenue and adjusted earnings growth to be driven by its military-focused education business and its nursing education platform

Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout

Annexon (NASDAQ:ANNX) executives outlined a series of expected clinical and regulatory updates across the company’s complement-focused pipeline during a session at the Jefferies Conference, highlighting programs in geographic atrophy, Guillain-Barré syndrome and cold agglutinin disease. Douglas Lov

Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in 2026, supported by a new generic launch, Primatene Mist growth and selected API sales from its China b

ALX Oncology Targets Key Readouts to Advance CD47, EGFR Cancer Drug Programs

ALX Oncology (NASDAQ:ALXO) executives said the company is focused on advancing two clinical-stage oncology programs, with upcoming data readouts expected to shape potential later-stage development plans for its lead CD47 program, evorpacept, and its EGFR-targeted antibody-drug conjugate, ALX2004. S

Get all your
news in one place.

100's of premium titles.
One news app.

Autodesk CFO Says MaintainX Deal Extends AI Push Across Asset Lifecycle

Autodesk (NASDAQ:ADSK) Chief Financial Officer Janesh Moorjani said the company’s recent business model changes and planned acquisition of MaintainX are intended to position the design software maker for broader participation across the full asset lifecycle, including operations and artificial intel

Advanced Energy Industries Sees Semiconductor, Data Center Strength as Margins Climb

Advanced Energy Industries (NASDAQ:AEIS) executives said the company is seeing broad-based strength across its semiconductor, data center and industrial and medical end markets, while also pointing to improving margins and additional manufacturing capacity expected to come online later this year. S

Veeva Systems Q1 Earnings Call Highlights

Veeva Systems (NYSE:VEEV) reported a strong start to the year, with Chief Executive Officer and Co-Founder Peter Gassner saying the company delivered results ahead of guidance as it expands its focus on artificial intelligence for the life sciences industry. On the earnings call, Gassner said total

IDT Q3 Earnings Call Highlights

IDT (NYSE:IDT) raised its full-year fiscal 2026 profit outlook after reporting higher third-quarter revenue, record gross profit and expanding margins, driven by growth in its higher-margin NRS, Fintech and net2phone segments. Chief Executive Officer Shmuel Jonas said the company’s year-over-year r

The Descartes Systems Group Q1 Earnings Call Highlights

The Descartes Systems Group (NASDAQ:DSGX) reported record quarterly results for the first quarter of fiscal 2027, with management pointing to growth in global trade intelligence, e-commerce customs entries, fleet performance management and transportation visibility despite a challenging freight mark

Netskope Q1 Earnings Call Highlights

Netskope (NASDAQ:NTSK) reported first-quarter fiscal 2027 revenue above its guidance and raised its full-year revenue outlook, as executives said demand remains healthy for the company’s cloud security, networking and emerging AI security products. Chief Executive Officer and Co-Founder Sanjay Beri

Broadcom Q2 Earnings Call Highlights

Broadcom (NASDAQ:AVGO) reported record fiscal second-quarter 2026 revenue and issued a sharply higher outlook for the current quarter, as President and CEO Hock Tan said demand for the company’s artificial intelligence semiconductors remains “simply insatiable.” On the earnings call, Tan said total

1 … 9 10 11 12

People

Michael Henderson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

National Insurance

Victoria Secret

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

385,212 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play